Episode 78: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue

What separates good drug companies from mediocre ones? Have biohackers sold out? And who's going to run the FDA?

Om Podcasten

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.